Stocks & Investing
Thu, November 13, 2025
Wed, November 12, 2025
Tue, November 11, 2025
Johnson & Johnson: 55-Year Dividend Growth Champion in Healthcare
//stocks-investing.news-articles.net/content/202 .. year-dividend-growth-champion-in-healthcare.html
Published in Stocks and Investing on Wednesday, November 12th 2025 at 20:48 GMT by The Motley Fool- 🞛 This publication is a summary or evaluation of another publication
- 🞛 This publication contains editorial commentary or bias from the source
Three Healthcare Stocks That Are Leading the 2025 Dividend Race
As the United States continues to grapple with rising healthcare costs and an aging population, the healthcare sector remains a perennial favorite for dividend investors. The Motley Fool’s latest research highlights three companies that stand out on a 2025 list of high‑yield, high‑growth healthcare stocks. The article – a deep‑dive into both fundamentals and forward‑looking trends – gives investors a clear playbook for adding dependable dividend income to their portfolios.
1. Johnson & Johnson (JNJ) – A Dividend‑Diligent Powerhouse
Why JNJ?
Johnson & Johnson has long been the benchmark for stability in the healthcare sector. The article notes that its diversified product mix – spanning pharmaceuticals, medical devices, and consumer health – has provided a cushion against downturns in any single segment. In 2024, the company reported a 4% increase in net sales and a 6% rise in adjusted earnings per share, translating into a 4.5% dividend yield—well above the sector average.
Key Highlights
- Dividend Growth Track Record: JNJ has raised its dividend for 55 consecutive years, a streak that surpasses the typical “dividend aristocrat” benchmark.
- Cash Flow Resilience: The company’s operating cash flow consistently exceeds $25 billion per year, ensuring ample liquidity to fund dividend payouts even in uncertain market conditions.
- Strategic Acquisitions: Recent acquisitions in the oncology and immunology space are expected to add 1–2% to the company's earnings in the next two years, further bolstering dividend potential.
Risks & Mitigations
The article discusses the potential for patent cliffs in its pharmaceutical segment and ongoing litigation over certain product lines. However, JNJ’s broad portfolio and strong R&D pipeline provide a buffer that most investors find reassuring.
2. UnitedHealth Group (UNH) – A Growth‑Yield Hybrid
Why UNH?
UnitedHealth Group is the world’s largest healthcare insurer, and its “Optum” subsidiary has positioned it at the intersection of health services and data analytics. The Motley Fool piece highlights that UNH’s dividend yield of 1.7% may seem modest, but the company’s compound annual growth rate (CAGR) of 10% over the past decade offsets this perception.
Key Highlights
- Expanding Service Lines: Optum’s analytics and workforce solutions are expected to become a major driver of revenue growth, especially as employers seek more cost‑effective health plans.
- Capital Efficiency: UNH’s payout ratio sits around 45%, leaving ample room to increase dividends as earnings expand.
- Diversified Risk Profile: The insurer’s mix of commercial, Medicare, and Medicaid segments reduces exposure to any single regulatory environment.
Risks & Mitigations
The article cautions about the political volatility surrounding healthcare reform. Nevertheless, UNH’s entrenched presence in the U.S. market and its proactive engagement with policymakers have historically mitigated these concerns.
3. Healthpeak Properties (PEP) – The Real‑Estate‑Backed Dividend Driver
Why Healthpeak?
Healthpeak Properties is a Real‑Estate Investment Trust (REIT) that specializes in healthcare facilities. While REITs often carry higher tax implications, the Motley Fool article argues that Healthpeak’s focus on high‑quality assets in growing markets makes it an attractive source of dividend income.
Key Highlights
- Stable Cash Flow: Healthpeak’s portfolio includes hospitals, outpatient centers, and senior housing facilities that provide long‑term lease agreements with strong credit tenants.
- Yield Advantage: The REIT currently offers a dividend yield of 6.8%, higher than the average U.S. REIT yield of 4.5%.
- Growth Prospects: The company plans to acquire several mid‑market facilities in the Southwest U.S., a region with strong demographic trends favoring healthcare expansion.
Risks & Mitigations
REITs are sensitive to interest‑rate changes, but the article points out that Healthpeak has a diversified debt structure and has been actively refinancing at favorable rates. Additionally, the healthcare industry’s regulatory environment is less volatile than other sectors, providing a degree of stability.
Common Themes Across the Trio
| Factor | Johnson & Johnson | UnitedHealth Group | Healthpeak Properties |
|---|---|---|---|
| Dividend Yield | 4.5% | 1.7% | 6.8% |
| CAGR (5‑yr) | 6.2% | 10.0% | 8.5% |
| Payout Ratio | 55% | 45% | 68% |
| Risk Profile | Patent cliffs, litigation | Healthcare reform, regulatory | Interest rates, REIT taxes |
The Motley Fool article stresses that while these companies operate in different sub‑segments of healthcare—consumer goods, insurance, and real estate—each shares a commitment to returning capital to shareholders. For investors seeking both income and growth, combining one or more of these stocks can provide a balanced exposure.
How the Article Positions Them in 2025
- Top Dividend Picks: The article identifies JNJ, UNH, and PEP as the leading names in the 2025 “Dividend‑Focused Healthcare List.”
- Future Outlook: Analysts project that the healthcare sector’s growth will outpace the broader market by 1–2% annually, largely due to demographic shifts and innovation.
- Portfolio Integration: The author recommends adding these stocks to a diversified portfolio of high‑yield equities, particularly those that have a history of dividend growth.
Additional Resources
The Motley Fool article also references several supporting reads that expand on the themes mentioned:
- “Dividend Growth Investing” – A primer on selecting stocks with a history of increasing payouts.
- “Healthcare Sector Outlook” – A detailed look at how macro trends will shape the industry in the next decade.
- “Real‑Estate Investment Trusts (REITs) Explained” – A guide to the tax and regulatory nuances of investing in REITs, with a focus on healthcare‑focused properties.
These links provide context for investors who want to understand the underlying drivers that make these healthcare stocks attractive dividend plays.
Takeaway
If you’re looking to add reliable, dividend‑paying stocks to your portfolio, the Motley Fool’s 2025 list offers a clear set of options:
- Johnson & Johnson – Classic stability and a long track record of dividend increases.
- UnitedHealth Group – A high‑growth insurer that’s set to benefit from evolving healthcare delivery models.
- Healthpeak Properties – A REIT that delivers above‑average yields with a robust, growing asset base.
By combining any of these picks—or all three—investors can enjoy a blend of income, growth, and resilience that aligns with the long‑term dynamics of the U.S. healthcare system.
Read the Full The Motley Fool Article at:
[ https://www.fool.com/investing/2025/11/12/3-healthcare-stocks-topping-a-2025-list-of-dividen/ ]
